Skip to main content

PGT-M conditions

This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact

Condition name Status OMIM number Documents
Generalized epilepsy with febrile seizures plus, type 3 (GEFSP3) approved 607681
Generalized epilepsy with febrile seizures plus, type 5, susceptibility to, (GEFSP5) approved 613060
Geroderma Osteodysplasticum approved 231070
Gerstmann-Straussler-Scheinker syndrome approved 137440
Glanzmann Thrombasthenia approved 273800
Glutaric Acidemia (aciduria) approved 231670
Glycogen Storage Disease II (Pompe Disease (early onset)) (GSD2) approved 232300
Glycogen storage disease IXa1 (GSD9A1) approved 306000
Glycogen storage disease IXa2 (GSD9A2) approved 306000
Glycogen storage disease IXb (GSD9B) approved 261750
Glycogen storage disease IXc (GSD9C) approved 613027
Glycogen storage disease IXd (GSD9D) approved 300559
Glycogen storage disease type 1B approved 232220
Glycogen Storage Disease Type 3 approved 232400
Glycogen Storage Disease Type 4, (GSD4) approved 232500
Glycogen Storage Disease Type Ia approved 232200
Glycogen storage disease V (GSD5) approved 232600
Glycogen storage disease VI (GSD6) approved 232700
Glycogen storage disease VII (GSD7) approved 232800
Goiter, Multinodular 1, with or without Sertoli-Leydig cell tumours (MNG1) approved 138800